You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 8,980,890

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,980,890 protect, and when does it expire?

Patent 8,980,890 protects KLISYRI and is included in one NDA.

This patent has forty-one patent family members in twenty-one countries.

Summary for Patent: 8,980,890

Title:	Compositions and methods of treating cell proliferation disorders
Abstract:	The invention relates to compounds and methods for treating cell proliferation disorders.
Inventor(s):	Hangauer, Jr.; David G. (Lancaster, NY)
Assignee:	Kinex Pharmaceuticals, LLC (Buffalo, NY)
Application Number:	12/950,764
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 8,980,890

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,980,890

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1836169	⤷ Sign Up	LUC00235	Luxembourg	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	301145	Netherlands	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	CA 2021 00042	Denmark	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	122021000066	Germany	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	2021C/001	Belgium	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	49/2021	Austria	⤷ Sign Up
European Patent Office	1836169	⤷ Sign Up	C01836169/01	Switzerland	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.